Back to Awarded Treatment Trials
Awarded Trial: 01-069
Grant ID
01-069
Illness
Bipolar Depression
Primary Drug/Intervention
Magnetic Seizure Therapy (MST)
Primary Dosage
Suprathreshold dose for seizures
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Completed
Investigator
Lisanby
Sample Size
20
Duration of Study Period for Each Subject
N/A
Outcome Measurements
CFQ, MMSE, SRT, AMI, HRSD
Results
Twenty medication resistant patients referred for electroconvulsive therapy received magnetic seizure therapy under controlled conditions. Sixty percent of patients experienced a 50% drop in depression ratings and 35% had a complete remission. The efficacy of MST was equivalent to that reported in the literature for ECT. Moreover, there were fewer cognitive side effects with MST.
Publication
N/A
Link
N/A
PI Name
Sarah Lisanby
Degree
MD
Center
Research Foundation for Mental Hygiene, Inc.
Institution
New York Psychiatric Institute Division
Address
1051 Riverside Drive
City or Town
New York
State or Province
NY
Zip or Postal Code
10032
Country
USA
Email Address
shl24@columbia.edu